Lee Ainslie Wave Life Sciences Ltd. Transaction History
Maverick Capital LTD
- $5.08 Billion
- Q1 2025
A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Maverick Capital LTD holds 8,261,683 shares of WVE stock, worth $50.1 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
8,261,683
Previous 8,261,242
0.01%
Holding current value
$50.1 Million
Previous $102 Million
34.68%
% of portfolio
1.31%
Previous 1.98%
Shares
14 transactions
Others Institutions Holding WVE
# of Institutions
205Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$110 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$75.8 Million0.2% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$40.8 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$38.5 Million0.56% of portfolio
-
M28 Capital Management LP Stamford, CT5.66MShares$34.3 Million48.34% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $526M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...